nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, Her2-metastatic breast cancer

Huober, J.Hamilton, E.Cortes, J.Ozyilkan, O.Chen, S.C.Petrakova, K.Manikhas, A.Jerusalem, G.Hegg, R.Chapman, S.Yang, Z.Chen, Y.Johnston, E.Martin, M.2022-06-142022-06-1420212296-5270http://hdl.handle.net/11727/7020enginfo:eu-repo/semantics/closedAccessnextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, Her2-metastatic breast cancerconferenceObject44244245000760622600451